Riber: 2024 business growth in line with guidance

Article

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/28/2026

1. NVDA
2. SPCX
3. KOD
4. USO
5. META

6. MU
7. MIRM
8. MDB
9. LLY
10. SPY

Top News Most Read Special Reports

January 29, 2025 2:00 AM EST

E-mail

2024 business growth in line with guidance

Revenues up +5% to €41.2m
Order book at end-2024: €21.7m

Bezons (France), January 29, 2025 – 8:00 am (CET) – RIBER, a global market leader for MBE equipment serving the semiconductor industry, is reporting its full-year revenues for 2024.

Change in revenues

€m	2024	2023	Change
First quarter	4.5	3.7	+20%
Second quarter	9.3	8.5	+10%
Third quarter	4.7	4.0	+19%
Fourth quarter	22.7	23.1	-2%
Full year	41.2	39.2	+5%

€m	2024	2023	Change
Systems	31.0	29.0	+7%
Services and accessories	10.2	10.3	-1%
Full year	41.2	39.2	+5%

2024 full-year revenues amounted to €41.2m, up 5% from 2023. This performance is fully aligned with the announced ambitions. In the fourth quarter of 2024, business remained strong, with revenues remaining steady despite a high basis of comparison with the fourth quarter of 2023.

This commercial dynamism demonstrates the strengthening of RIBER's positions in the MBE market for both research and industrial production.

MBE systems revenues reached €31.0m, up 7%. A total of 12 systems were delivered over the year, compared with 13 in 2023.

Revenues for services and accessories came to €10.2m, virtually unchanged from 2023.

The geographical breakdown of revenues for 2024 full-year was as follows: Asia 57.3%, Europe 35.7%, and North America 7.1%.

Order book developments

At December 31 (€m)	2024	2023	Change
Systems	16,7	20.2	-17%¹
Services and accessories	5,0	6.1	-18%
Full year	21,7	26.3	-17%

At December 31, 2024, the consolidated order book remained at a solid level of €21.7m, reflecting the sustained deliveries at the end of the year.

The order book for MBE systems came to €16.7m with a total of 7 systems, including 5 production machines. It increases after factoring in the two orders announced in January 2025 for a production system in Europe and a research system in the USA, both scheduled for delivery in 2025.

Orders for services and accessories amounted to €5.0m.

Outlook

Given its solid revenue growth, RIBER reaffirms its objective of achieving further earnings growth in 2024.

In an environment marked by accelerating technological innovation and growing demand for advanced semiconductor materials, RIBER is pursuing its ambitious growth strategy based on enhancing its technological leadership and expanding its markets through the integration of the silicon photonics sector and the development of high value-added solutions for quantum materials.

For 2025, given the composition of the order book at December 31, 2024, and the outlook for orders to be delivered this year, RIBER is forecasting further growth in revenues compared with 2024.

Next date: RIBER will announce its 2024 full-year earnings on April 9, 2025 (before start of trading).

About RIBER

Founded in 1964, RIBER is the global market leader for MBE - molecular beam epitaxy - equipment. It designs and produces equipment for the semiconductor industry, and provides scientific and technical support for its clients (hardware and software), maintaining their equipment and optimizing their performance and output levels.
Accelerating the performance of electronics, RIBER’s equipment performs an essential role in the development of advanced semiconductor systems that are used in numerous applications, from information technologies to photonics (lasers, sensors, etc.), 5G telecommunications networks and research, including quantum computing.

RIBER is a BPI France-approved innovative company and is listed on the Euronext Growth Paris market (ISIN: FR0000075954).
www.riber.com

Contacts

RIBER : Annie Geoffroy| tel: +33 (0)1 39 96 65 00 | [email protected]
CALYPTUS : Cyril Combe | tel: +33 (0)1 53 65 68 68 | [email protected]

1 Increasing when factoring in the two orders recorded in January 2025.

Attachment